Exercise-induced Changes in Soluble ST2 Concentrations in Marathon Runners
- PMID: 30339660
- PMCID: PMC6430603
- DOI: 10.1249/MSS.0000000000001806
Exercise-induced Changes in Soluble ST2 Concentrations in Marathon Runners
Abstract
Purpose: Previous studies have suggested that extreme endurance exercise may induce cardiac microdamage that could lead to subsequent myocardial fibrosis. Soluble suppression of tumorigenicity 2 (sST2) is a cardiac biomarker for assessment of myocardial fibrosis, inflammation, and strain. We evaluated baseline and exercise-induced sST2 concentrations in a heterogeneous cohort of marathon runners to identify predictors for sST2 concentrations.
Methods: Ninety-two runners supplied demographic data, health status, physical activity levels, and marathon experience. Before (baseline) and immediately after (finish) the marathon, blood was collected for analysis of sST2 and cardiac troponin I (cTnI).
Results: Eighty-two participants (45 ± 8 yr, 79% male) finished the race in 227 ± 28 min at 92% (88%-94%) of their predicted maximum heart rate (exercise intensity). sST2 concentrations increased in all runners, from 34 (25-46) ng·mL to 70 (53-87) ng·mL (P < 0.001), and cTnI increased from 9 (5-21) ng·L to 60 (34-102) ng·L (P < 0.001). sST2 concentrations were higher in the fastest marathon runners. Sex and marathon personal best time were associated with baseline sST2 (R = 0.27); baseline sST2, weight loss, and exercise intensity during marathon were associated with finish sST2 (R = 0.54); baseline sST2, height, sex, and weekly training hours were associated with the exercise-induced increase in sST2 (R = 0.47). We observed no association between sST2 and cTnI concentrations.
Conclusion: An exercise-induced increase in sST2 was observed in all marathon runners with sST2 concentrations exceeding cutoff values both at baseline (48%) and finish (94%). Faster runners had higher sST2 concentrations. Our data suggest complex variables determine sST2 concentrations in marathon runners.
Figures


Similar articles
-
Effect of Health and Training on Ultrasensitive Cardiac Troponin in Marathon Runners.J Appl Lab Med. 2019 Mar;3(5):775-787. doi: 10.1373/jalm.2018.026153. Epub 2018 May 22. J Appl Lab Med. 2019. PMID: 31639753
-
Predictors of cardiac troponin release after a marathon.J Sci Med Sport. 2015 Jan;18(1):88-92. doi: 10.1016/j.jsams.2013.12.002. Epub 2014 Jan 2. J Sci Med Sport. 2015. PMID: 24440407
-
Evolution of the slopes of ST2 and galectin-3 during marathon and ultratrail running compared to a control group.Clin Chem Lab Med. 2020 Jan 28;58(2):314-321. doi: 10.1515/cclm-2019-0555. Clin Chem Lab Med. 2020. PMID: 31622239
-
Effects of medium- and long-distance running on cardiac damage markers in amateur runners: a systematic review, meta-analysis, and metaregression.J Sport Health Sci. 2021 Mar;10(2):192-200. doi: 10.1016/j.jshs.2019.10.003. Epub 2019 Dec 27. J Sport Health Sci. 2021. PMID: 33742602 Free PMC article.
-
An evaluation of the training determinants of marathon performance: A meta-analysis with meta-regression.J Sci Med Sport. 2020 Feb;23(2):182-188. doi: 10.1016/j.jsams.2019.09.013. Epub 2019 Oct 18. J Sci Med Sport. 2020. PMID: 31704026
Cited by
-
The effect of exercise on flow-mediated dilation in people with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.Front Endocrinol (Lausanne). 2024 Mar 26;15:1347399. doi: 10.3389/fendo.2024.1347399. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38596227 Free PMC article.
-
Biomarker sST2 in Adults with Transposition of the Great Arteries Palliated by Mustard Procedure: A Five-Year Follow-up.Pediatr Cardiol. 2023 Apr;44(4):927-932. doi: 10.1007/s00246-023-03105-0. Epub 2023 Jan 27. Pediatr Cardiol. 2023. PMID: 36705684
-
Circulating Gal-3 and sST2 are associated with acute exercise-induced sustained endothelial activation: Possible relevance for fibrosis development?Exp Physiol. 2023 Oct;108(10):1259-1267. doi: 10.1113/EP091277. Epub 2023 Aug 12. Exp Physiol. 2023. PMID: 37572028 Free PMC article.
-
Mountain Ultra-Marathon (UTMB) Impact on Usual and Emerging Cardiac Biomarkers.Front Cardiovasc Med. 2022 Mar 24;9:856223. doi: 10.3389/fcvm.2022.856223. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35402558 Free PMC article.
-
Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers.Int J Mol Sci. 2023 Feb 15;24(4):3881. doi: 10.3390/ijms24043881. Int J Mol Sci. 2023. PMID: 36835293 Free PMC article. Review.
References
-
- Eijsvogels TM, Hoogerwerf MD, Maessen MF, et al. Predictors of cardiac troponin release after a marathon. J Sci Med Sport. 2015;18(1):88–92. - PubMed
-
- Aengevaeren VL, Hopman MT, Thijssen DH, van Kimmenade RR, de Boer MJ, Eijsvogels TM. Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls. Int J Cardiol. 2017;227:430–5. - PubMed
-
- Scharhag J, George K, Shave R, Urhausen A, Kindermann W. Exercise-associated increases in cardiac biomarkers. Med Sci Sports Exerc. 2008;40(8):1408–15. - PubMed
-
- Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc. 2011;43(10):1819–27. - PubMed
-
- van de Schoor FR, Aengevaeren VL, Hopman MT, et al. Myocardial fibrosis in athletes. Mayo Clin Proc. 2016;91(11):1617–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials